In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be ...

The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a genetically inherited risk ...

This is a major source of cardiovascular morbidity and mortality. We have never been able to treat lipoprotein(a) until now.” ...

An experimental drug could be game-changing for millions of Americans with a higher genetic risk of cardiovascular disease.

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

In an exclusive interview with NBC News, President Donald Trump said there were methods that would allow him to seek a third ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

Discover how the experimental drug lepodisiran dramatically lowers lipoprotein(a) levels, potentially transforming treatment ...